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Sascha N. Goonewardena, MD, Anthony Gemignani, MD, Adam Ronan, MD,
Samip Vasaiwala, MD, John Blair, MD, J. Matthew Brennan, MD, Dipak P. Shah, MD,
Kirk T. Spencer, MD, FACC
Chicago, Illinois
O B J E C T I V E S We sought to compare the value of serial assessment with hand-carried ultrasound
(HCU) of the inferior vena cava (IVC) with brain natriuretic peptide (BNP) to identify patients with acute
decompensated heart failure (ADHF) who will be readmitted or seek emergency department treatment
after hospital discharge.
B A C KG ROUND Congestive heart failure (CHF) is a leading cause for hospitalization and, once
hospitalized, patients with CHF frequently are readmitted. To date, no reliable index exists that can be
used to predict whether patients with ADHF can be discharged with low readmission likelihood.
METHOD S A total of 75 patients who were admitted with a primary diagnosis of ADHF were followed.
All patients were assessed at admission and discharge with the use of routine clinical evaluation, BNP
measurement, and HCU evaluation of the IVC by physicians with limited training in ultrasound.
R E S U L T S During the 30-day follow-up, 31 patients were rehospitalized or presented to the
emergency department. Patients who were subsequently readmitted could not be differentiated from
those who were not readmitted by their demographics, comorbidities, vital signs, presence of
symptoms/signs suggestive of persistent congestion, hospital length of stay, or net volume removal.
Routine laboratory tests, including assessment of renal function, also failed to predict readmission with
the exception of serum sodium. Although admission BNP was similar in patients readmitted and not
readmitted, pre-discharge log-transformed BNP was greater in patients who subsequently were
readmitted. Patients who required repeat hospitalization had a larger IVC size on admission as well as
at discharge. In addition, patients who were readmitted had persistently plethoric IVCs with lower IVC
collapsibility indexes. At discharge, only serum sodium, log-transformed BNP, IVC size, and collapsibility
were statistically signiﬁcant predictors of readmission.
CONC L U S I O N S This study conﬁrms that, once hospitalized, patients with CHF frequently are
readmitted. Bedside evaluation of the IVC with a HCU device at the time of admission and discharge, as
well as pre-discharge BNP, identiﬁed patients admitted with ADHF who were more likely to be
readmitted to the hospital. (J Am Coll Cardiol Img 2008;1:595–601) © 2008 by the American College
of Cardiology Foundation
From the University of Chicago Hospitals, Chicago, Illinois.Manuscript received March 11, 2008; revised manuscript received June 19, 2008, accepted June 25, 2008.
C
O
a
n
w
f
d
c
g
c
d
s
m
t
e
u
c
u
n
a
c
s
w
f
i
w
H
w
w
t
M
P
H
p
t
a
a
m
p
g
r
T
C
m
a
a
s
m
i
R
a
i
d
i
f
4
f
m
p
s
p
u
w
t
a
i
t
m
c
s
m
w
s
A
A
A
h
B
C
E
H
I
I
c
I
o
I
t
l
v
p
LV left ventricle
J A C C : C A R D I O V A S C U L A R I M A G I N G , V O L . 1 , N O . 5 , 2 0 0 8
S E P T E M B E R 2 0 0 8 : 5 9 5 – 6 0 1
Goonewardena et al.
Hand-Carried Ultrasound in Decompensated CHF
596ongestive heart failure (CHF) is a major
source of cardiovascular morbidity and a
leading cause for hospitalization among
patients older than the age of 65 years.
nce hospitalized, patients with CHF frequently
re readmitted with recurrent symptoms. To date,
o reliable index exists that can be used to predict
hether patients with acute decompensated heart
ailure (ADHF) are adequately treated and can be
ischarged with low readmission likelihood. Be-
ause many of these readmissions are due to con-
estion, the accurate determination of volume status
ould prove useful to establish the suitability for
ischarge.
See page 602
Traditional bedside physical examina-
tion of a hospitalized CHF patient’s vol-
ume status involves the assessment of sev-
eral signs that have poor specificity and
sensitivity or are difficult to perform accu-
rately. Invasive measurements of right
atrial pressure and pulmonary capillary
wedge pressure are the gold standards for
the determination of intravascular volume
status but are impractical in most patients.
Brain natriuretic peptide (BNP) has
proven beneficial in the diagnosis of CHF.
In addition to its diagnostic potential,
BNP may have a role in the serial assess-
ment and monitoring of patients with
ADHF (1–4).
We hypothesized that because ultra-
sound evaluation of the inferior vena
cava (IVC) size and collapsibility is an
accurate predictor of right atrial pres-
ure, this assessment might prove to be helpful in
onitoring patients with ADHF (5,6). However,
he cost and inconvenience of serial bedside
valuation of the IVC with large full-featured
ltrasound platforms limits the applicability in
linical settings. Recent advances in hand-carried
ltrasound (HCU) devices have made this tech-
ology ideal for point-of-care clinical assessments
nd their utility has been demonstrated in diverse
linical settings (7–14). In addition, multiple
tudies have demonstrated that noncardiologists
ith limited training and experience can perform
ocused HCU examinations with high reproduc-
bility and accuracy (10,15–19). Therefore, in this
ork, we sought to compare the value of serial
ed
tide
re
nd
ter
er ofCU assessment of IVC size and collapsibility cith that of BNP to identify ADHF patients who
ill be readmitted or seek emergency department
reatment after hospital discharge.
E T H O D S
atients admitted to the University of Chicago
ospital with a primary diagnosis of ADHF were
rospectively screened. Patients were excluded if
hey were transferred from an outside hospital,
dmitted to an intensive care unit, admitted with an
cute coronary syndrome, required renal replace-
ent therapy, or were unwilling or unable to
rovide informed consent. The treating cardiolo-
ist, who was blinded to the results of the HCU
esults, made management and discharge decisions.
he Institutional Review Board of the University of
hicago approved the study.
Vital signs, CHF symptoms and signs, cardiac
edications, and serum chemistries were noted on
dmission and at discharge. Dietary and medicine
dherence were assessed with a subjective 4-point
cale. N-terminal pro-BNP was measured on ad-
ission and discharge by electrochemiluminescence
mmunoassay in a standardized hospital laboratory.
eadmission or emergency department visits were
scertained by review of medical records and phone
nterview 30 days after hospital discharge.
Internal medicine residents with minimal echocar-
iographic exposure and no previous formal training
n ultrasonography performed the HCU studies. Be-
ore data acquisition, each of the residents underwent
h of formal didactic ultrasound training and per-
ormed 20 sonographer-supervised acquisitions and
easurements of the IVC from the subcostal ap-
roach. Previous research has demonstrated a 90%
uccess rate for obtaining IVC measurements for
hysicians with this amount of training (20).
Within 12 h of hospital admission, all patients
nderwent a brief echocardiographic examination
ith a HCU device (Optigo, Philips Medical Sys-
ems, Andover, Massachusetts). A second HCU ex-
mination was performed at the end of the hospital-
zation once the treating physicians made the decision
o discharge the patient. Care was taken to obtain the
aximal IVC diameter throughout the respiratory
ycle. The maximum (IVCmax) and minimum (IVC-
niff) diameter after having the patient sniff were
easured 2.0 cm from the IVC right atrial junction
ith the use of electronic calipers. Images were not
tored. The IVC collapsibility index (IVCCI) wasB B R E V I A T I O N S
N D A C R O N YM S
DHF acute decompensat
eart failure
NP brain natriuretic pep
HF congestive heart failu
F ejection fraction
CU hand-carried ultrasou
VC inferior vena cava
VCCI inferior vena cava
ollapsibility index
VCmaxmaximum diame
f the inferior vena cava
VCsniffminimum diamet
he inferior vena cava
ogBNP log-transformed
alues for brain natriuretic
eptidealculated as (IVCmax  IVCsniff)/(IVCmax).
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597tatistical analysis. Categorical data are presented as
ercentages; normally distributed continuous data as
ean  SD; and non-normally distributed variables
s median and interquartile range. Log-transformed
alues for BNP (logBNP) were used to reduce the
ffect of the typical skewness of BNP values. Patients
ere divided into 2 groups, no readmission and
eadmission, according to a composite outcome mea-
ure that included emergency department visit or
ospital readmission at 30 days after the index hospi-
alization. Statistical differences between these groups
ere assessed with the use of unpaired t tests and
hi-square analysis. Binary logistic regression was
pplied to test discharge variables’ abilities to predict
eadmission. The 3 most significant variables on
nivariable analysis were added to the regression by
he use of forward stepwise analysis. Receiver operator
urves were calculated for continuous variables signif-
cant on univariable analysis. Optimal cutoff points
ere selected by maximizing accuracy. A p value
0.05 was considered statistically significant. Intraob-
erver variability is reported as the coefficient of
ariation.
E S U L T S
total of 75 patients were enrolled with a mean age
f 61 years (53% men). Left ventricular (LV) systolic
ysfunction was common (80%), and the mean ejec-
Table 1. Demographics and Past Medical History in All
Patients
All Patients
Age, yrs 61 15
Male 53%
EF, % 29 16
EF 40% 80%
ICM 42%
Previous CHF admission (6 months) 59%
Prior admission (6 months) 1 (2)
NYHA functional class I to II 30%
Hypertension 87%
Diabetes 41%
COPD 19%
CrCl 60 ml/min/1.73 m2 61%
Atrial ﬁbrillation 16%
Depression 15%
Good diet compliance 43%
Good drug compliance 71%
Doctor contact 51%
CHF  congestive heart failure; COPD  chronic obstructive pulmonary
disease; CrCl  creatinine clearance; EF  ejection fraction; ICM  ischemic
cardiomyopathy; NYHA  New York Heart Association.ion fraction (EF) was 29  16%. Most patients hadrevious admissions for CHF in the last 6 months
59%), with the average number of CHF admissions
umbering 1.6  3.0 (range 0 to 20). Comorbidities
ere common (Table 1), as were typical CHF signs
nd symptoms (Table 2). Most patients were already
n an outpatient CHF regimen with a high use of
ngiotensin-converting enzyme inhibitors, beta-
lockers, and diuretics (Table 3). The mean admission
NP level was elevated at 12,163  15,923 pg/ml
range 232 to 67,494 pg/ml). The IVC on admission
as plethoric, with 67% of the patients having a
iameter 2.0 cm (mean 2.3  0.5 cm) and 90% of
atients had a collapsibility index 50% (mean 27 
1%). Inferior vena cava size and logBNP were poorly
orrelated (r  0.23), as were IVC collapsibility and
ogBNP (r  0.12).
The average hospital length of stay was 4.1 2.5
ays (range 1 to 14 days). Net diuresis averaged 6.1
6.6 liters, with significant improvement in CHF
igns and symptoms (Table 2). There were signifi-
ant reductions in systolic blood pressure, diastolic
lood pressure, and heart rate and small-but-
ignificant reductions in serum sodium and in-
reases in bicarbonate with therapy (Table 4). Dur-
ng the hospitalization, there was a 40% decrease in
NP values. Although IVCmax decreased and
VCCI increased, 44% of the patients continued to
ave an IVC diameter 2.0 cm, and 66% had IVC
ollapsibility50% at discharge. Ninety-six percent
f patients were prescribed a diuretic at discharge,
nd the rates of angiotensin-converting enzyme
nhibitor and beta-blocker use were increased com-
ared with admission.
During the 30-day follow-up, 31 patients were
ehospitalized or presented to the emergency de-
artment. A total of 84% of the patients in whom
Table 2. Vital Signs and CHF Symptoms/Signs in All Patients
All Patients
Admission Discharge p Value
HR (beats/min) 87 19 80 14 0.001
SBP (mm Hg) 127 28 117 24 0.01
DBP (mm Hg) 72 14 62 13 0.001
Net diuresis (liters) — 4.4 (5.9) —
LOS (days) — 4.1 2.5 —
PND 51% 16% 0.001
Abd distention 40% 14% 0.01
Dyspnea 92% 16% 0.001
Increased JVP 92% 79% 0.05
Edema 72% 12% 0.001
Abd  abdominal; CHF  congestive heart failure; DBP  diastolic blood
pressure; HR  heart rate; JVP  jugular venous pulse; LOS  length of stay;
PND  paroxysmal nocturnal dyspnea; SBP  systolic blood pressure.
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598he readmission diagnosis was known were admit-
ed for CHF (63% CHF, 12% non-CHF, 24%
nknown). On admission to the hospital, patients
ho were subsequently readmitted could not be
istinguished from those who were not readmitted
y age, EF, CHF class, comorbidities, vital signs, or
ymptoms. Although medication compliance and
hysician follow-up did not differ between groups,
ore patients in the group not readmitted had
elf-reported adherence to dietary sodium restric-
ion (62% vs. 26%; p  0.04). Patients who were
lready being treated with a beta-blocker or diuretic
t admission were more likely to be readmitted.
Admission serum laboratory values, including
NP, were indistinguishable between groups, with
he exception of the admission sodium level, which
as slightly lower in patients who were readmitted
137 vs. 140 mEq/l; p  0.001). Although initial
VCmax was slightly larger in readmitted patients,
he IVCCI was similar between groups. Before
npatient treatment, most patients had either an
VCmax 2.0 cm or IVCCI 50% in both the
ot-readmitted (91%) and readmitted group (96%).
Patients who were subsequently readmitted could
ot be differentiated from those who were not read-
itted by their discharge vital signs or the presence of
ymptoms/signs suggestive of persistent congestion.
dmission weight, discharge weight, and weight
hanges were statistically equal in the 2 groups. Pa-
ients who successfully remained out of the hospital
id not have a longer length of stay or greater net
olume removal. Discharge medications did not differ
etween groups, although inotropic drug usage was
ore common in patients readmitted.
Patients who remained out of the hospital in
ollow-up were more likely to have had a beta-
locker, aldosterone blocker, or diuretic started
uring their admission, which primarily reflects the
elatively lower use of these agents in these patients
Table 3. Medication Usage in All Patients
All Patients
Admission Discharge p Value
ACEi or ARB 70% 85% 0.10
Beta blocker 74% 81% 0.32
Aldo blocker 21% 37% 0.03
Diuretic 85% 96% 0.02
H/I 10% 12% 0.60
Inotrope — 17% —
Nesiritide — 1% —
ACEi  angiotensin-converting enzyme inhibitor; Aldo  aldosterone; ARB 
angiotensin receptor blocker; H/I  hydralazine-isosorbide.n admission rather than the failure to start them inhe readmission group. Pre-discharge routine labo-
atory values, including those reflecting renal func-
ion, were not useful in distinguishing between
roups with the exception of serum sodium, which
as lower in readmitted patients (134 vs. 137
Eq/l; p  0.004). Serum BNP had extensive
verlap between groups and was not statistically
ifferent; however, pre-discharge logBNP was
reater in patients subsequently readmitted.
As a group, the HCU IVC measurements taken
re-discharge were statistically different between
he patients who were readmitted and not readmit-
ed. Patients who required repeat hospitalization
ad larger IVC maximal diameters and lower col-
apsibility indexes (Table 5). Using traditional cut-
ffs for increased right atrial pressure (IVC 2.0
m or IVCCI 50%), we found that patients
equiring rehospitalization had abnormal pre-
ischarge values of IVC size nearly 3 times as often
21% vs. 61%; p  0.001) and abnormal IVC
ollapsibility 1.5 times more frequently (47% vs.
1%; p  0.01) compared with the group of
atients who were not rehospitalized.
Of all variables at discharge, only serum sodium
p  0.002), logBNP (p  0.005), IVCmax (p 
.001), and IVC collapsibility (p  0.002) were
tatistically significant predictors of readmission. In
ultivariate analysis with the 3 most significant
ariables, IVCmax and logBNP were the most
owerful predictors (odds ratios 10.3 and 6.1, re-
pectively, regression model z  23.4  2.3 [IVC-
ax]  1.8 [logBNP]  0.25 [serum sodium]).
eceiver operator curves for these variables demon-
trated area under the curves of 0.69, 0.78, and 0.74
or BNP, IVCmax, and IVC collapsibility, respec-
ively (Fig. 1). Optimal cutoff points for predicting
eadmission were 2,327 for BNP (sensitivity 82%,
pecificity 56%), 2.0 cm for IVCmax (sensitivity
1%, specificity 72%), and 38% for IVC collapsibil-
ty (sensitivity 67%, specificity 75%). Intraobserver
Table 4. Serum Chemistries in All Patients
All Patients
Admission Discharge p Value
Sodium (mEq/l) 138 4 136 4 0.001
Bicarbonate (mEq/l) 24 4 28 4 0.001
BUN (mg/dl) 35 24 36 23 0.43
Creatinine (mg/dl) 1.6 0.7 1.5 0.6 0.07
Creatinine clearance
(ml/min/1.73 m2)
50 22 51 20 0.55
Hemoglobin (g/dl) 12.2 1.9 12.0 1.9 0.79BUN  blood urea nitrogen.
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599ariability was 7.5% for IVCmax and 9.7 % for IVC
ollapsibility.
I S C U S S I O N
his study confirms that, once hospitalized, pa-
ients with CHF frequently are readmitted because
f recurrent symptoms. The readmission rate at 30
ays in this study was 41%, which is similar to
reviously reported values of 30% to 44% within 1
o 6 months post-discharge (1–4,21). None of the
linical predictors were useful for distinguishing
atients who would be readmitted from those not
equiring rehospitalization, with the exception of
notrope use during the acute treatment, which has
een noted previously (4). Although some studies
uggest patients with lower LVEFs are more likely
o be readmitted (2,3), others similar to our study
id not find differences in LVEF between groups
1,4).
Most readmissions in CHF patients reflect that
ome patients with CHF, because of either dietary
r medical noncompliance, reaccumulate excessive
uid. This observation is supported by the fact that
elf-reported adherence to a low-sodium diet was
ess common in patients readmitted. However, it is
lso likely that a large proportion of patients with
HF are undertreated and, although symptomati-
ally improved, not euvolemic at the time of dis-
harge despite the clinician’s impression to the
ontrary. This hypothesis is consistent with our
tudy, which shows that after a mean of 4 days of
herapy and 6-liter net diuresis, there was a marked
eduction in symptoms despite persistent elevations
n BNP and nearly two-thirds of patients having
ersistently reduced IVC collapsibility.
Traditional bedside evaluation of a hospitalized
HF patient’s volume status involves the assess-
ent of lower-extremity edema, lung fields, and
ugular venous pulse, which have poor accuracy for
Table 5. BNP, IVC Size, and Collapsibility in All Patients and 2 S
All Patients
Admission Discharge p Value
BNP (pg/ml) 6,139 (9,714) 3,497 (4,824) —
logBNP 3.8 0.5 3.5 0.6 0.001
IVCmax (cm) 2.3 0.5 2.0 0.6 0.001
IVCsniff (cm) 1.7 0.7 1.2 0.8 0.001
IVCCI (%) 27 21 45 27 0.001
Admission and discharge values in all patients compared with paired t test. No
BNP  brain natriuretic peptide; IVC inferior vena cava; IVCCI  inferior vena
of the inferior vena cava; logBNP  log-transformed values for brain natriuretiolume status. Consistent with these limitations,hysical examination parameters, including vital
igns, were no different between patients who were
eadmitted and those were not. Although deviation
rom dry weight can be a powerful clinical tool, an
stablished dry weight was not known in the ma-
ority of these patients. Routine clinical chemistries
lso were unable to predict patient readmission
ther than serum sodium levels, likely reflecting a
ubgroup of patients with more severe CHF. Con-
istent with previous ADHF studies, pre-discharge
NP differed between patients readmitted and
hose not readmitted, whereas admission BNP did
ot (1–4).
Several echocardiographic parameters have been
hown to correlate with LV filling pressures and
herefore might prove useful for assessing whether
atients with ADHF have been adequately diuresed
22). The mitral inflow pattern has proved to be
0.0
0.2
0.4
0.6
0.8
1.0
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IVCma
Figure 1. Receiver-Operator Curves
Receiver-operator curves for logBNP (solid line) and IVCmax (dashe
to predict hospital readmission. The area under the curve is greater
max, indicating a greater likelihood of correctly predicting the need
repeat hospitalization after inpatient therapy for acutely decompen
congestive heart failure. logBNP  log-transformed values for brain
roups
Admission Disch
Readmit Readmit p Value No Readmit Re
7 (10,091) 5,982 (9,208) — 2,106 (3,298) 4,888
7 0.6 3.8 0.5 0.28 3.3 0.7 3.6
2 0.5 2.4 0.4 0.02 1.7 0.6 2.3
5 0.7 1.9 0.6 0.03 0.9 0.7 1.5
1 23 23 16 0.10 57 27 36
dmit and readmit subgroups compared with unpaired t test.
collapsibility index; IVCmax  maximum diameter of the inferior vena cava; IVCs
tide.1.0
x
d line)
for IVC-
for
sated
natri-ubg
arge
No admit p Value
6,17 (5,112) —
3.  0.4 0.04
2.  0.5 0.001
1.  0.7 0.001
3  22 0.002
rea
cava niff  minimum diameteruretic peptide; IVCmax  maximum diameter of the inferior vena cava.
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600nferior to BNP for predicting readmission in ADHF
3,4) and performs poorly in CHF patients with
reserved LVEF. Tissue Doppler-derived E/E= has
hown promise in predicting post-discharge events in
atients with ADHF (2). However, this technique
equires sophisticated ultrasound devices as well as
ubstantial expertise to perform and interpret. Ultra-
ound examination of IVC size and collapsibility has
roven to be a robust marker of right atrial pressure, a
urrogate of volume status (5,6,20). A major advan-
age of this approach is that IVC evaluation can be
erformed with a HCU ultrasound device that has
imited 2-dimensional imaging capabilities (14,20).
he substantially lower cost of HCU devices as well as
heir increased portability greatly increases the utility
or bedside assessment. Their diagnostic utility when
perated by personnel with limited training has been
roven in multiple clinical settings (10,15–20).
In our study, HCU evaluation of IVC demon-
trated that patients discharged after treatment for
DHF who were subsequently readmitted had
ignificantly greater IVCs and lower IVC collaps-
bility that are consistent with persistent elevation
n right atrial pressure. These readmitted patients
ad significant net diuresis (7.2 liters) and marked
mprovement in symptoms. However, we hy-
othesize that, despite this significant diuresis,
hese patients were likely discharged as persistently
ypervolemic. Patients who are discharged withat high risk of re-admission after de- ultrasound device inuctuations in sodium intake without precipitating
vert CHF symptoms requiring readmission.
tudy limitations. There are several limitations to
his study, including the relatively small sample size.
n addition, these data do not confirm that, if a
linician acted on an abnormal pre-discharge log-
NP or IVCmax by keeping a patient in the
ospital longer for further diuresis, that outcome
ould be altered. Finally, no analysis of the cost-
ffectiveness of these strategies is available.
O N C L U S I O N S
edside evaluation of the IVC with a HCU device
t the time of admission and discharge as well as
re-discharge BNP identified patients admitted
ith ADHF who were more likely to be readmitted
o the hospital. Because the rate of hospital read-
ission for CHF patients within 6 months is as
igh as 50%, any disease-management strategy that
ould be used to reduce readmissions would prove
aluable. It is possible that measurement of the IVC
ould be used to accurately identify patients who
equire earlier intensive therapy, more prolonged
npatient diuresis or closer outpatient follow-up to
revent their subsequent unanticipated hospital re-
dmission.
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